...
首页> 外文期刊>Advances in materials science and engineering >Synthesis of Two Novel Homologous Polyphosphoesters Containing Aminophosphonate Units and Cytotoxicity of Some Low-Molecular and Polymeric Aminophosphonate Derivatives
【24h】

Synthesis of Two Novel Homologous Polyphosphoesters Containing Aminophosphonate Units and Cytotoxicity of Some Low-Molecular and Polymeric Aminophosphonate Derivatives

机译:两种新型的含氨基膦酸酯单元的同源多聚磷酸酯的合成及某些低分子和聚合的氨基膦酸酯衍生物的细胞毒性

获取原文
           

摘要

Two novel polyphosphoesters containing anthracene- and furan-derived aminophosphonate moieties, namely, poly[oxyethylene(aminophosphonate-co-H-phosphonate)]s P-12 and P-13, were synthesized through an addition of poly(oxyethylene H-phosphonate) to 9-anthrylidene-furfurylamine and characterized. The novel polyphosphoester P-12 and a series of previously described anthracene-derived compounds including Schiff bases S-1 and S-2, α-aminophosphonates A-3–A-6, bis-aminophosphonate B-6, two enantiomers A-5a and A-5b, and polyphosphoesters P-8–P-11 containing aminophosphonate units were screened for antitumor activity against a panel of human leukemic cell lines, using cisplatin as a reference cytotoxic agent. As concluded from the cytotoxicity assays, both precursors S-1 and S-2 presented similar cytotoxicity profiles that are cisplatin-like only in the REH cell line. Leader compound of the α-aminophosphonates is A-4 with cell death-inducing properties fully equaling those of the referent drug in all of the screened leukemic cell lines with the only exception being the AML histological subtype HL-60. Some of the polymeric analogues elicited moderate (P-10 and P-12) to low (P-11) cytotoxic activity, whereas the polyphosphoesters P-8 and P-9 produced in vitro antitumor effects largely surpassing cisplatin’s. The compounds P-8, P-9, and A-4 could be potential new materials for anticancer therapeutic purposed.
机译:通过添加聚(氧乙烯-H-膦酸酯),合成了两种含有蒽和呋喃衍生的氨基膦酸酯基团的新颖的聚磷酸酯,即聚[氧乙烯(氨基-膦酸酯-co-H-膦酸酯)] P-12和P-13。并以9-蒽亚糠基胺为特征。新型多磷酸酯P-12和一系列先前所述的蒽衍生化合物,包括席夫碱S-1和S-2,α-氨基膦酸酯A-3–A-6,双氨基膦酸酯B-6,两种对映异构体A-5a使用顺铂作为参考细胞毒剂,对A-5b和A-5b以及含有氨基膦酸酯单元的聚磷酸酯P-8-P-11进行抗人白血病细胞系抗肿瘤活性的筛选。从细胞毒性测定中得出的结论,前体S-1和S-2都显示出相似的细胞毒性谱,仅在REH细胞系中类似顺铂。 α-氨基膦酸酯的前导化合物是A-4,在所有筛选出的白血病细胞系中,其细胞死亡诱导特性与参考药物完全相同,唯一例外的是AML组织学亚型HL-60。一些聚合类似物引起中等(P-10和P-12)至低(P-11)细胞毒活性,而聚磷酸酯P-8和P-9在体外产生的抗肿瘤作用大大超过了顺铂。化合物P-8,P-9和A-4可能是潜在的用于抗癌治疗的新材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号